Login

The GO Foundation South Australia launches on Friday, February 15, at the Adelaide Fringe Festival along the Torrens River. 00:10:00

Share On Facebook Share On Twitter

Riber appoints Philippe Ley as CEO and board member

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Barrick Highlights Strategic Growth in Gold and Copper Mining
00:10:00
ACCO Brands CEO Boris Elisman on Navigating Supply Chain Challenges and Strategic Growth | Boris Elisman, CEO , ACCO Brand.
00:10:00
Mutares (MUX): Revitalizing Underperforming Companies and Market Outlook | Johannes Laumann , CIO, Mutares.
00:10:00
Tom Williams on Diversification and Future Growth at Downing Renewables & Infrastructure | Tom William, Manager, Downing Renewables and Infrastructure Trust PLC.
00:10:00
Exploring Private Equity Insights with Ian Snow, CEO of Snow Phipps Group
00:10:00
Gold Terra Resource Corp Presentation at Virtual Investor Conference
00:10:00
Designing Success: Hannah Dale's Entrepreneurial Journey with Wrendale Designs | Hannah Dale - founder of Wrendale Designs
00:10:00
JCPenney Faces Challenges with Cash Flow and Customer Engagement Amid Strategy Shift
00:10:00
Advancing Greenland's Rare Earth Potential: The Cavanna Field Project
00:00:00
Exercise Test Predicts Noncardiovascular and Cardiovascular Death- Dr. Thomas Allison, a Cardiologist at Mayo Clinic
00:10:00
Warryn Robertson on Delivering Value in Global Listed Infrastructure | Warryn Robertson - Portfolio Manager and Analyst at Lazard Asset Management
00:10:00
Global Forces Unveiled: Insights with Lord William Hague | Schroders Investor Download Podcast

© 2026 Nehu